[A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein mucin chelated to the radioisotope yttrium-90. Yttrium Y 90 monoclonal antibody BrE-3 binds to tumor cells expressing epithelial glycoprotein mucin, selectively delivering a cytotoxic dose of beta radiation. (NCI04) ( NCI )]
UMLS (NCI) C0935731Yttrium Y 90 Monoclonal Antibody BrE-3
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor